XML 27 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 2 - Revision of Previously Issued Financial Statements
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Accounting Changes and Error Corrections [Text Block]
Note
2.
Revision of Previously Issued Financial Statements for Immaterial Misstatements
 
In the
third
quarter of
2018,
we determined accumulated DDA and DDA expense at Casa Berardi, a business unit within our Hecla Quebec Inc. subsidiary, were understated for the periods from
June 1, 2013
through
June 30, 2018
as a result of errors in calculation from the date of acquisition of Casa Berardi as noted below:
 
 
i.
understatement of DDA by approximately
$35.5
million in the aggregate over
5
1/2
years. The error in calculation resulted from the foreign exchange translation of accumulated DDA and DDA expense from Canadian dollars (“CAD”) to U.S. dollars (“USD”), which was incorrectly set up in the financial reporting system to use the average exchange rate for the respective reporting period, when the historical exchange rate should have been used. The CAD to USD exchange rate at
June 1, 2013
was
0.9646
and has subsequently weakened over the intervening periods, resulting in an understatement of accumulated DDA and DDA expense during the periods from
June 1, 2013
to
June 30, 2018.
The adjustments in the
third
quarter of
2018
to record the cumulative amounts related to this understatement for prior periods through 
June 30, 2018
were:
 
Condensed Consolidated Balance Sheet (Unaudited)
 
(in millions)
 
Credit - Accumulated DDA (recorded within properties, plants, equipment and mineral interests, net)
  $
(36.2
)
Debit - Inventories: concentrates, doré, and stockpiled ore
   
1.1
 
Debit - Accumulated deficit
   
30.3
 
         
Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited)
 
 
 
 
Debit - DDA expense
   
5.0
 
Credit - Net foreign exchange gain (loss)
   
(0.2
)
Net increase to net loss for the nine months ended September 30, 2018
   
(4.8
)
 
 
ii.
overstatement of DDA of approximately
$14.2
million in the aggregate over
5
1/2
years related to the accelerated conversion of costs from the mineral interest asset, which represents the value of the undeveloped mineral interest and is
not
depletable, to the mineral properties asset, which represents the value of proven and probable reserves and is depletable. The error in calculation arose from the incorrect use of fair value information available on the per ounce value at the date of acquisition and resulted in the overstatement of the proven and probable reserves asset, which is subject to depletion, and an understatement of the undeveloped mineral interest asset, both of which are categories reported within properties, plants, equipment and mineral interests, net on the balance sheet. The overstatement of the conversions to the proven and probable reserves asset during the periods from
January 1, 2014
through
June 30, 2018
resulted in overstatements of accumulated DDA and DDA expense in each of these periods. The adjustments in the
third
quarter of
2018
to record the cumulative amounts related to this overstatement for prior periods through 
June 30, 2018
were:
 
Condensed Consolidated Balance Sheet (Unaudited)
 
(in millions)
 
Debit - Accumulated DDA (recorded within properties, plants, equipment and mineral interests, net)
  $
14.2
 
Credit - Deferred tax liability
   
(3.8
)
Credit - Accumulated deficit
   
(7.7
)
         
Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited)
 
 
 
 
Credit - DDA expense
   
(3.7
)
Debit - Income tax provision (benefit)
   
1.0
 
Net decrease to net loss for the nine months ended September 30, 2018
   
2.7
 
 
 
We assessed the materiality of the effect of the errors on our prior quarterly and annual financial statements, both quantitatively and qualitatively, in accordance with the SEC’s Staff Accounting Bulletin ("SAB")
No.
99,
“Materiality,” and SAB
No.
108,
“Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements,” and concluded the errors were
not
material to any of our previously issued financial statements. Consequently, we will correct these errors prospectively and revise our financial statements when the consolidated balance sheets, statements of operations and comprehensive income and cash flows for such prior periods are included in future filings (the "Revisions"). The Revisions had
no
net impact on our sales or net cash provided by operating activities for any period presented.
 
The following tables present a summary of the impact, by financial statement line item, of the Revisions for the
three
months ended
March 31, 2017, 
June 30, 2017
and
September 30, 2017,
the
six
months ended
June 30, 2017,
the 
nine
months ended
September 30, 2017,
as of and for the year ended
December 31, 2017,
and for the year ended
December 31, 2016: 
 
   
Three Months Ended September 30, 2017
 
(in thousands, except per share amounts)
 
As Previously
Reported
   
Adjustment
   
As Revised
 
Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation, depletion and amortization
  $
28,844
    $
674
    $
29,518
 
Total cost of sales
   
97,202
     
674
     
97,876
 
Gross profit
   
43,637
     
(674
)
   
42,963
 
Income (loss) from operations
 
 
20,942
   
 
(674
)
 
 
20,268
 
Foreign exchange (loss) gain
   
(4,764
)
   
(153
)
   
(4,917
)
Total other (expense) income
   
(24,931
)
   
(153
)
   
(25,084
)
(Loss) income before income taxes
 
 
(3,989
)
 
 
(827
)
 
 
(4,816
)
Income tax benefit (provision)
   
5,401
     
(271
)
   
5,130
 
Net income
  $
1,412
    $
(1,098
)
  $
314
 
Income applicable to common shareholders
 
$
1,274
   
$
(1,098
)
 
$
176
 
Comprehensive income
   
9,048
     
(1,098
)
   
7,950
 
Basic income per common share after preferred dividends
 
$
   
$
   
$
 
Diluted income per common share after preferred dividends
 
$
   
$
   
$
 
 
 
   
Nine Months Ended September 30, 2017
 
(in thousands, except per share amounts)
 
As Previously
Reported
   
Adjustment
   
As Revised
 
Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation, depletion and amortization
  $
83,365
    $
3,621
    $
86,986
 
Total cost of sales
   
307,902
     
3,621
     
311,523
 
Gross profit
   
109,760
     
(3,621
)
   
106,139
 
Income (loss) from operations
 
 
40,788
   
 
(3,621
)
 
 
37,167
 
Foreign exchange (loss) gain
   
(10,909
)
   
651
     
(10,258
)
Total other (expense) income
   
(54,935
)
   
651
     
(54,284
)
(Loss) income before income taxes
 
 
(14,147
)
 
 
(2,970
)
 
 
(17,117
)
Income tax benefit (provision)
   
18,377
     
(813
)
   
17,564
 
Net income
  $
4,230
    $
(3,783
)
  $
447
 
Income applicable to common shareholders
 
$
3,816
   
$
(3,783
)
 
$
33
 
Comprehensive income
   
17,948
     
(3,783
)
   
14,165
 
Basic income per common share after preferred dividends
 
$
0.01
   
$
(0.01
)
 
$
 
Diluted income per common share after preferred dividends
 
$
0.01
   
$
(0.01
)
 
$
 
                         
Condensed Consolidated Statements of Cash Flows (Unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
Net income
  $
4,230
    $
(3,783
)
  $
447
 
Depreciation, depletion and amortization
   
87,634
     
3,621
     
91,255
 
Foreign exchange loss (gain)
   
11,171
     
(651
)
   
10,520
 
Deferred income taxes
   
(24,280
)
   
813
     
(23,467
)
Cash provided by operating activities
 
$
74,115
   
$
   
$
74,115
 
 
 
   
As of and for the Year Ended December 31, 2017
 
(in thousands)
 
As Previously
Reported
   
Adjustment
   
As Revised
 
Condensed Consolidated Balance Sheet
 
 
 
 
 
 
 
 
 
 
 
 
Inventories: Concentrate, doré, and stockpiled ore
  $
28,455
    $
911
    $
29,366
 
Total current assets
   
320,325
     
911
     
321,236
 
Properties, plants, equipment and mineral interests, net
   
2,020,021
     
(20,710
)
   
1,999,311
 
Total assets
 
 
2,364,957
   
 
(19,799
)
 
 
2,345,158
 
Deferred tax liability
   
121,546
     
2,806
     
124,352
 
Total liabilities
   
881,075
     
2,806
     
883,881
 
Accumulated deficit
   
(195,484
)
   
(22,605
)
   
(218,089
)
Total shareholders' equity
   
1,483,882
     
(22,605
)
   
1,461,277
 
Total liabilities and shareholders' equity
 
 
2,364,957
   
 
(19,799
)
 
 
2,345,158
 
                         
Consolidated Statements of Operation and Comprehensive (Loss) Income
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation, depletion and amortization
  $
116,062
    $
4,537
    $
120,599
 
Total cost of sales
   
420,789
     
4,537
     
425,326
 
Gross profit
   
156,986
     
(4,537
)
   
152,449
 
Income (loss) from operations
 
 
64,643
   
 
(4,537
)
 
 
60,106
 
Foreign exchange (loss) gain
   
(10,300
)
   
620
     
(9,680
)
Total other (expense) income
   
(68,283
)
   
620
     
(67,663
)
(Loss) income before income taxes
 
 
(3,640
)
 
 
(3,917
)
 
 
(7,557
)
Income tax (provision) benefit
   
(19,879
)
   
(1,084
)
   
(20,963
)
Net (loss) income
  $
(23,519
)
  $
(5,001
)
  $
(28,520
)
(Loss) income applicable to common shareholders
 
$
(24,071
)
 
$
(5,001
)
 
$
(29,072
)
Comprehensive income (loss)
   
(12,290
)
   
(5,001
)
   
(17,291
)
Basic (loss) income per common share after preferred dividends
 
$
(0.06
)
 
$
(0.01
)
 
$
(0.07
)
Diluted (loss) income per common share after preferred dividends
 
$
(0.06
)
 
$
(0.01
)
 
$
(0.07
)
                         
Condensed Consolidated Statements of Cash Flows
 
 
 
 
 
 
 
 
 
 
 
 
Net (loss) income
  $
(23,519
)
  $
(5,001
)
  $
(28,520
)
Depreciation, depletion and amortization
   
121,930
     
4,537
     
126,467
 
Foreign exchange loss (gain)
   
10,828
     
(620
)
   
10,208
 
Deferred income taxes
   
18,308
     
1,084
     
19,392
 
Cash provided by operating activities
 
$
115,878
   
$
   
$
115,878
 
 
 
 
   
Three Months Ended March 31, 2017
 
(in thousands)
 
As Previously
Reported
   
Adjustment
   
As Revised
 
Condensed Consolidated Statements of Operation and Comprehensive Income (Loss) (Unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation, depletion and amortization
  $
28,952
    $
1,483
    $
30,435
 
Total cost of sales
   
107,628
     
1,483
     
109,111
 
Gross profit
   
34,916
     
(1,483
)
   
33,433
 
Income from operations
 
 
15,871
   
 
(1,483
)
 
 
14,388
 
Foreign exchange gain (loss)
   
(2,262
)
   
2
     
(2,260
)
Total other expense
   
(18,108
)
   
2
     
(18,106
)
Income (loss) before income taxes
 
 
(2,237
)
 
 
(1,481
)
 
 
(3,718
)
Income tax (provision) benefit
   
29,071
     
(271
)
   
28,800
 
Net income
  $
26,834
    $
(1,752
)
  $
25,082
 
Income applicable to common shareholders
 
$
26,696
   
$
(1,752
)
 
$
24,944
 
Comprehensive income
   
30,038
     
(1,752
)
   
28,286
 
Basic income per common share after preferred dividends
 
$
0.07
   
$
   
$
0.07
 
Diluted income per common share after preferred dividends
 
$
0.07
   
$
   
$
0.07
 
                         
Condensed Consolidated Statements of Cash Flows (Unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
Net income
  $
26,834
    $
(1,752
)
  $
25,082
 
Depreciation, depletion and amortization
   
29,590
     
1,483
     
31,073
 
Foreign exchange (gain) loss
   
506
     
(2
)
   
504
 
Deferred income taxes
   
(21,234
)
   
271
     
(20,963
)
Cash provided by operating activities
 
$
38,285
   
$
   
$
38,285
 
 
 
   
Three Months Ended June 30, 2017
 
(in thousands)
 
As Previously
Reported
   
Adjustment
   
As Revised
 
Condensed Consolidated Statements of Operation and Comprehensive Income (Loss) (Unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation, depletion and amortization
  $
25,569
    $
1,464
    $
27,033
 
Total cost of sales
   
103,072
     
1,464
     
104,536
 
Gross profit
   
31,207
     
(1,464
)
   
29,743
 
Income from operations
 
 
3,975
   
 
(1,464
)
 
 
2,511
 
Foreign exchange gain (loss)
   
(3,883
)
   
803
     
(3,080
)
Total other income (expense)
   
(11,896
)
   
803
     
(11,093
)
Income (loss) before income taxes
 
 
(7,921
)
 
 
(661
)
 
 
(8,582
)
Income tax (provision) benefit
   
(16,095
)
   
(271
)
   
(16,366
)
Net income (loss)
  $
(24,016
)
  $
(932
)
  $
(24,948
)
Income (loss) applicable to common shareholders
 
$
(24,154
)
 
$
(932
)
 
$
(25,086
)
Comprehensive income (loss)
   
(21,138
)
   
(932
)
   
(22,070
)
Basic income (loss) per common share after preferred dividends
 
$
(0.06
)
 
$
   
$
(0.06
)
Diluted income (loss) per common share after preferred dividends
 
$
(0.06
)
 
$
   
$
(0.06
)
 
 
   
Six Months Ended June 30, 2017
 
(in thousands)
 
As Previously
Reported
   
Adjustment
   
As Revised
 
Condensed Consolidated Statements of Operation and Comprehensive Income (Loss) (Unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation, depletion and amortization
  $
54,521
    $
2,947
    $
57,468
 
Total cost of sales
   
210,700
     
2,947
     
213,647
 
Gross profit
   
66,123
     
(2,947
)
   
63,176
 
Income from operations
 
 
19,846
   
 
(2,947
)
 
 
16,899
 
Foreign exchange gain (loss)
   
(6,145
)
   
805
     
(5,340
)
Total other income (expense)
   
(30,004
)
   
805
     
(29,199
)
Income (loss) before income taxes
 
 
(10,158
)
 
 
(2,142
)
 
 
(12,300
)
Income tax (provision) benefit
   
12,976
     
(542
)
   
12,434
 
Net income (loss)
  $
2,818
    $
(2,684
)
  $
134
 
Income (loss) applicable to common shareholders
 
$
2,542
   
$
(2,684
)
 
$
(142
)
Comprehensive income (loss)
   
8,900
     
(2,684
)
   
6,216
 
Basic income (loss) per common share after preferred dividends
 
$
0.01
   
$
(0.01
)
 
$
 
Diluted income (loss) per common share after preferred dividends
 
$
0.01
   
$
(0.01
)
 
$
 
                         
Condensed Consolidated Statements of Cash Flows (Unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
Net income
  $
2,818
    $
(2,684
)
  $
134
 
Depreciation, depletion and amortization
   
56,908
     
2,947
     
59,855
 
Foreign exchange (gain) loss
   
5,201
     
(805
)
   
4,396
 
Deferred income taxes
   
(22,113
)
   
542
     
(21,571
)
Cash provided by operating activities
 
$
45,821
   
$
   
$
45,821
 
 
 
   
For the Year Ended December 31, 2016
 
(in thousands)
 
As Previously
Reported
   
Adjustment
   
As Revised
 
Consolidated Statements of Operation and Comprehensive (Loss) Income
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation, depletion and amortization
  $
116,126
    $
7,505
    $
123,631
 
Total cost of sales
   
454,451
     
7,505
     
461,956
 
Gross profit
   
191,506
     
(7,505
)
   
184,001
 
Income (loss) from operations
 
 
116,944
   
 
(7,505
)
 
 
109,439
 
Foreign exchange (loss) gain
   
(2,926
)
   
189
     
(2,737
)
Total other (expense) income
   
(19,969
)
   
189
     
(19,780
)
(Loss) income before income taxes
 
 
96,975
   
 
(7,316
)
 
 
89,659
 
Income tax (provision) benefit
   
(27,428
)
   
(662
)
   
(28,090
)
Net (loss) income
  $
69,547
    $
(7,978
)
  $
61,569
 
(Loss) income applicable to common shareholders
 
$
68,995
   
$
(7,978
)
 
$
61,017
 
Comprehensive income (loss)
   
67,576
     
(7,978
)
   
59,598
 
Basic (loss) income per common share after preferred dividends
 
$
0.18
   
$
(0.02
)
 
$
0.16
 
Diluted (loss) income per common share after preferred dividends
 
$
0.18
   
$
(0.02
)
 
$
0.16
 
                         
Condensed Consolidated Statements of Cash Flows
 
 
 
 
 
 
 
 
 
 
 
 
Net (loss) income
  $
69,547
    $
(7,978
)
  $
61,569
 
Depreciation, depletion and amortization
   
117,413
     
7,505
     
124,918
 
Foreign exchange loss (gain)
   
4,649
     
(189
)
   
4,460
 
Deferred income taxes
   
2,112
     
662
     
2,774
 
Cash provided by operating activities
 
$
225,328
   
$
   
$
225,328